The global eClinical solutions market size was estimated at USD 8.25 billion in 2022 and is expected to hit around USD 27.39 billion by 2032 with a CAGR of 12.8% from 2023 to 2032.
Key Takeaways:
- North America led the market with the largest market share of 52% in 2022.
- The CTMS segment dominated the market for eClinical solutions and accounted for the largest revenue share of over 22% in 2022.
- By Delivery Mode, the web-hosted segment dominated the market with the largest revenue share of over 75% in 2022.
- By Development Phase, the phase III segment dominated the eClinical solutions market and accounted for the largest revenue share of over 54% in 2022.
- The CROs segment dominated the market for eClinical solutions and held the largest revenue share of over 37.06% in 2022.
The report has been prepared with extensive primary and secondary research. Primary research involved the majority of the research efforts, wherein analysts carried out interviews with key manufacturers, end-consumers, industry experts, independent consultants, and opinion-makers.
Secondary research involved referring to company websites, annual reports, investors’ presentations, press releases, patents database, import-export statistics, and other relevant documents to understand the eClinical solutions market. Secondary research also included Precedence Research internal repository, industry associations, government agencies, and proprietary databases. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global eClinical solutions market.
Request a Sample Copy of This Report@ https://www.precedenceresearch.com/sample/1092
The report includes an executive summary, along with a market overview and an elaborative analysis of the growth behavior in various segments that are included in the scope of the study. The report also covers a high-level picture of the production processes and product specifications pertaining to eClinical solutions. Furthermore, the report provides insights on the changing competitive dynamics, which serve as valuable tools for existing market players as well as for entities interested in participating in the market.
In addition to the above, the report also explores the competitive landscape, in terms of identifying the global players operating in the eClinical solutions market and comprehensive profiles of the key players, including their business overview, key financials, market shares, market footprints, production capacities, and strategic initiatives including new product developments, mergers & acquisitions, etc.
Some of the prominent players in the global eClinical solutions market include:
- PAREXEL International
- Oracle Corp.
- Bioclinica
- Medidata Solution
- DATATRAK
- ERT Clinical
- CRF Health
- eClinicalWorks
- OmniComm Systems
- IBM Watson Health
- eClinical Solutions
Segments Covered in the Report
By Product
- EDC & CDMS
- eCOA
- Clinical Data Integration Platforms
- CTMS
- Safety Solutions
- RTSM
- Clinical Analytics platforms
- eTMF
By Development Phase
- Phase IV
- Phase III
- Phase II
- Phase I
By Delivery Mode
- Licensed Enterprise
- Web-hosted
- Cloud-based
By End-Use
- CROs
- Hospitals
- Academic Institutes
- Medical Device Manufacturers
- Pharma & Biotech Organizations
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
Precedence Research employs a comprehensive and iterative research methodology focused on minimizing deviance to provide the most accurate estimates and forecasts possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation which looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:
Preliminary data mining
Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.
Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, and pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.
Statistical model
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.
Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:
- Market drivers and restraints, along with their current and expected impact
• Raw material scenario and supply v/s price trends
• Regulatory scenario and expected developments
• Current capacity and expected capacity additions up to 2030
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2017 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global eClinical Solutions Market, By Product
7.1. eClinical Solutions Market, by Product Type, 2020-2027
7.1.1. EDC & CDMS
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. eCOA
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Clinical Data Integration Platforms
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. CTMS
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Safety Solutions
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. RTSM
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Clinical Analytics platforms
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. eTMF
7.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global eClinical Solutions Market, By Development Phase
8.1. eClinical Solutions Market, by Development Phase, 2020-2027
8.1.1. Phase IV
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Phase III
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Phase II
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Phase I
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global eClinical Solutions Market, By Delivery Mode
9.1. eClinical Solutions Market, by Delivery Mode, 2020-2027
9.1.1. Licensed Enterprise
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Web-hosted
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Cloud-based
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global eClinical Solutions Market, By End-Use
10.1. eClinical Solutions Market, by End-Use, 2020-2027
10.1.1. CROs
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Academic Institutes
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Medical Device Manufacturers
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Pharma & Biotech Organizations
10.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global eClinical Solutions Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End-Use (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Development Phase (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Delivery Mode (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End-Use (2016-2027)
Chapter 12. Company Profiles
12.1. PAREXEL International
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Oracle Corp.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Bioclinica
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medidata Solution
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. DATATRAK
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ERT Clinical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. CRF Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinicalWorks
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. OmniComm Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IBM Watson Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. eClinical Solutions
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Blog: https://www.pharma-geek.com
0 Comments